More choice for you: Dexcom G7 with myLoop
Dexcom G7 is now approved for use with myLoop, powered by CamAPS FX!
This update offers an additional option within the myLoop system to support your day-to-day management of type 1 diabetes.
What does this mean for you
Dexcom G7 is a new CGM option with myLoop.
As Dexcom begins retiring Dexcom G6, we recommend contacting your diabetes healthcare team to learn more about switching to Dexcom G7.
Dexcom G6 will remain fully supported while available in your market
Frequently Asked Questions
Yes. Health Canada has approved Dexcom G7 for use with myLoop, powered by CamAPS FX. Commercial availability will be announced separately.
We do not have a confirmed commercial availability date yet. We are currently targeting the end of 2026 or early 2027. We will share an update as soon as the timing is confirmed.
Not yet. Health Canada approval does not mean the Dexcom G7 use with myLoop is commercially available in Canada. Please continue using your currently supported setup until we announce availability and next steps.
Yes. New prospective users can begin the myLoop onboarding process now. The use of Dexcom G7 with myLoop will become available at a later date, once commercial availability is confirmed.
Not yet. The use of Dexcom G7 with myLoop has been approved, but commercial availability in Canada has not been confirmed. You may begin the onboarding process for new prospective patients now. We will inform healthcare professionals when myLoop with Dexcom G7 becomes available and provide transition guidance.
Yes. Dexcom G6 remains a supported option with CamAPS FX. There is no need to switch sensors now. But, as Dexcom has announced plans to discontinue Dexcom G6 as it transitions to its next-generation sensor technology. We therefore recommend that current Dexcom G6 users discuss switching to Dexcom G7 with their diabetes care team to ensure continuity of care.
Pending confirmation from Dexcom. We will share verified information when available.
Dexcom G7 combines the sensor and transmitter in one device and has a 30-minute warm-up, compared with 120 minutes for Dexcom G6. More information: https://www.dexcom.com/en-CA/g6-transition-to-g7
Guidance and training materials will be available for the Dexcom G7 setup. We will share the appropriate instructions when the option becomes commercially available in Canada.
Contact & support
Questions about Dexcom sensors: Contact Dexcom Customer Support
Questions about myLoop and CamAPS FX: Contact your local mylife Customer Service team
Disclaimer:The product images are for illustrative purposes only. mylife, myLoop and YpsoPump are registered trademarks of mylife Diabetes Care or of its affiliates. CamAPS is a registered trademark of CamDiab Ltd. Dexcom and Dexcom G7 are registered trademarks of Dexcom, Inc. in the United States and/or other countries. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by mylife Diabetes Care is under license. Other trademarks are the property of their respective owners.
For safety information on the products mentioned, see mylife-diabetescare.com/safety